Industry News
Pharmaceutical Industry News
Johnson & Johnson CEO: Consumer health split won’t interfere with our ‘more aggressive’ approach to M&A
Johnson & Johnson CEO: Consumer health split won't interfere with our 'more aggressive' approach to M&A kdunleavy Tue, 01/25/2022 - 11:34
Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label use
Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label use aliu Tue, 01/25/2022 - 11:19
Samsung Biologics outlines mRNA ambitions as “Super Plant” speeds toward completion
Samsung Biologics outlines mRNA ambitions as "Super Plant" speeds toward completion fkansteiner Tue, 01/25/2022 - 10:56
EpiPen rival raises $39M to fund smaller, longer-lasting product
EpiPen rival raises $39M to fund smaller, longer-lasting product ntaylor Tue, 01/25/2022 - 09:11
Roche’s aim to widen Evrysdi’s label nabs speedy FDA review in young spinal muscular atrophy patients
Roche's aim to widen Evrysdi's label nabs speedy FDA review in young spinal muscular atrophy patients fkansteiner Tue, 01/25/2022 - 09:11
WuXi STA opens new sterile manufacturing line at Wuxi City site
WuXi STA opens new sterile manufacturing line at Wuxi City site jkeenan Tue, 01/25/2022 - 08:31
Topical combo based on Pfizer and Novartis drugs advances after clearing early clinical test
Topical combo based on Pfizer and Novartis drugs advances after clearing early clinical test ntaylor Tue, 01/25/2022 - 06:46
Novaliq eyes dermatology opportunity, spinning off 3 programs and securing $15M for clinical trials
Novaliq eyes dermatology opportunity, spinning off 3 programs and securing $15M for clinical trials ntaylor Tue, 01/25/2022 - 06:42
J&J extends long-acting injectable biologic pact after Midatech clears early milestone
J&J extends long-acting injectable biologic pact after Midatech clears early milestone ntaylor Tue, 01/25/2022 - 06:39
Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform
Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform kdunleavy Tue, 01/25/2022 - 00:48
FDA bans Lilly, Regeneron antibody use in COVID-19 patients infected by omicron
FDA bans Lilly, Regeneron antibody use in COVID-19 patients infected by omicron kdunleavy Mon, 01/24/2022 - 17:26
Argenx, already deep into its Vyvgart launch, charts course to become immunology ‘powerhouse’: CEO
Argenx, already deep into its Vyvgart launch, charts course to become immunology 'powerhouse': CEO fkansteiner Mon, 01/24/2022 - 14:11
Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape disrupts confirmatory trial
Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape disrupts confirmatory trial aliu Mon, 01/24/2022 - 11:34
On second thought, Oncopeptides decides not to give up on Pepaxto in the U.S., but won’t say why
On second thought, Oncopeptides decides not to give up on Pepaxto in the U.S., but won't say why kdunleavy Mon, 01/24/2022 - 11:28
Pfizer takes a surprising hit to its rare disease plan as FDA snubs new growth deficiency med
Pfizer takes a surprising hit to its rare disease plan as FDA snubs new growth deficiency med aliu Mon, 01/24/2022 - 10:27
With omicron on the prowl, FDA extends inspection pause into February
With omicron on the prowl, FDA extends inspection pause into February fkansteiner Mon, 01/24/2022 - 10:01
AbbVie’s Skyrizi nabs psoriatic arthritis nod, its second, shortly after Rinvoq
AbbVie's Skyrizi nabs psoriatic arthritis nod, its second, shortly after Rinvoq fkansteiner Mon, 01/24/2022 - 09:03
AstraZeneca taps E! host Nina Parker for asthma campaign as it hopes new drug Tezspire can ‘break the cycle’
AstraZeneca taps E! host Nina Parker for asthma campaign as it hopes new drug Tezspire can 'break the cycle’ badams Mon, 01/24/2022 - 08:59
Gilead’s Veklury expands FDA nod to patients outside the hospital as oral version heads to trial
Gilead's Veklury expands FDA nod to patients outside the hospital as oral version heads to trial aliu Mon, 01/24/2022 - 06:57
BDSI readies liquid migraine medicine launch but stays away from ‘broad blast’ marketing campaign
BDSI readies liquid migraine medicine launch but stays away from 'broad blast' marketing campaign sharon.coey Mon, 01/24/2022 - 04:29